Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.

Inflammatory/immunological process and glial contribution are suggested in the pathophysiology of schizophrenia. We investigated peripheral benzodiazepine receptors in brains of patients with chronic schizophrenia, which were reported to be located on mitochondria of glial cells, using [11C]DAA1106 with positron emission tomography. Fourteen patients and 14 age- and sex-matched normal controls participated in this study. PET data were analysed by two-tissue compartment model with metabolite-corrected plasma input. Clinical symptoms were assessed using the Positive and Negative Syndrome Scale. There was no significant difference between [11C]DAA1106 binding of the cortical regions of normal controls and patients with schizophrenia, whereas the patients showed a positive correlation between cortical [11C]DAA1106 binding and positive symptom scores. There was also a positive correlation between [11C]DAA1106 binding and duration of illness. Although the correlations need to be interpreted very cautiously, involvement of glial reaction process in the pathophysiology of positive symptoms or progressive change of schizophrenia might be suggested.

[1]  T. Suslow,et al.  Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  H. Nawa,et al.  Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines , 2006, Neuroscience Research.

[3]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[4]  F. Yasuno,et al.  Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 , 2008, Biological Psychiatry.

[5]  X. Zhang,et al.  Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. , 2004, The Journal of clinical psychiatry.

[6]  Y. Sudo,et al.  Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study , 2001, Psychiatry and clinical neurosciences.

[7]  R. Pioli,et al.  The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.

[8]  S. Eiduson.  Biochemistry and behavior , 1965 .

[9]  Makoto Sawada,et al.  Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies , 2008, The Journal of Neuroscience.

[10]  Ryuji Nakao,et al.  Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  J. Feldon,et al.  Peripheral benzodiazepine receptors reflect trait (early handling) but not state (avoidance learning) , 2002, Pharmacology Biochemistry and Behavior.

[12]  Norbert Müller,et al.  COX-2 inhibition in schizophrenia and major depression. , 2008, Current pharmaceutical design.

[13]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[14]  D. B. Stone.  Biochemistry and Behavior. , 1966 .

[15]  K O Lim,et al.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[16]  Abraham Weizman,et al.  Acute and Repeated Swim Stress Effects on Peripheral Benzodiazepine Receptors in the Rat Hippocampus, Adrenal, and Kidney , 2001, Neuropsychopharmacology.

[17]  Takahiro A. Kato,et al.  Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro , 2007, Schizophrenia Research.

[18]  Emmanuel Stip,et al.  Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review , 2008, Biological Psychiatry.

[19]  K. Suk,et al.  The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production , 2008, Journal of neurochemistry.

[20]  K. Labuzek,et al.  Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. , 2004, Polish journal of pharmacology.

[21]  S Ogawa,et al.  Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106. , 1999, Life sciences.

[22]  S. Hume,et al.  Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.

[23]  René S. Kahn,et al.  Microglia activation in schizophrenia , 2010, NeuroImage.

[24]  J. Ryu,et al.  Inhibition of lipopolysaccharide‐induced cyclooxygenase‐2, tumor necrosis factor‐α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 , 2002, Journal of neurochemistry.

[25]  B. Gabryel,et al.  Chlorpromazine and loxapine reduce interleukin-1β and interleukin-2 release by rat mixed glial and microglial cell cultures , 2004, European Neuropsychopharmacology.

[26]  J. Lieberman,et al.  Longitudinal study of brain morphology in first episode schizophrenia , 2001, Biological Psychiatry.

[27]  J. Bart,et al.  P-glycoprotein activity and biological response. , 2005, Toxicology and applied pharmacology.

[28]  G. Deuschl,et al.  Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro , 2003, Neurobiology of Disease.

[29]  T. Pollmächer,et al.  Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever , 2009, Psychoneuroendocrinology.

[30]  K. Labuzek,et al.  Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-α and nitric oxide by rat microglial cells , 2003, Neurochemistry International.

[31]  J. Jakubikova,et al.  PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro. , 2002, Neoplasma.

[32]  Tetsuya Suhara,et al.  [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. , 2003, Nuclear medicine and biology.

[33]  Rudi A. Dierckx,et al.  Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.

[34]  S. Chaki,et al.  Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. , 1999, European journal of pharmacology.

[35]  Yuji Nagai,et al.  Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.

[36]  S. Akhondzadeh,et al.  Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial , 2007, Schizophrenia Research.

[37]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[38]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[39]  A. L. Goldin,et al.  Neurobiology of Disease , 2014 .